Acute Porphyria Drug Database

Monograph

R06AX25 - Mizolastine
Propably not porphyrinogenic
PNP

Rationale
Probably insignificant hepatic metabolic load.
Chemical description
Antihistamine with long duration of effect. Adminstered as depot tablet 10 mg/d. In main parts excreted in unchanged form after glucuronidation. Only a minor part metabolized by CYP 3A4.

Similar drugs
Explore alternative drugs in similar therapeutic classes R06A / R06AX or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Mizollen · Mizollen 10 mg, tabletten met gereguleerde afgifte
Belgium
Mizollen · Mizollen 10 mg compr. lib. modif.
United Kingdom
Mistamine · Mistamine 10mg modified-release tablets · Mizollen · Mizollen 10mg modified-release tablets
Luxembourg
MIZOLLEN
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙